Sunshine Biopharma, Inc. SBFMW
Oct 30, 2026, 9:38 AM EDT
- YTD
- 0.00%
- 1 year
- 0.00%
- Market cap
- 4.18M
- Revenue (ttm)
- 32.96M
- Profit margin
- -12.82%
- EPS (ttm)
- -2.21
- YTD return
- 0.00%
- 1-year return
- 0.00%
- Open
- 0.2428
- Previous close
- 0.0255
- Day's range
- 0.0255 – 0.0255
- 52-week range
- 0.0255 – 0.0255
- Beta
- -1.04
2Y 0.0000 (0.00%)
Key statistics
- Enterprise value
- 0
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.01
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 41.60%
- Free cash flow
- -12.84M
- Total cash
- 12.21M
- Total debt
- 556.55K
- Return on equity
- -17.98%
- Short % of float
- 0.00%
- 50-day average
- 0.00
- 200-day average
- 0.00
Next earnings
Consensus EPS estimate 0.00.
About Sunshine Biopharma, Inc.
Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is based in Fort Lauderdale, Florida.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- United States
- Website
- sunshinebiopharma.com
News
No recent headlines
Headlines appear here as they are published.
Your note
Sign in to keep a note on SBFMW — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Citadel Advisors Llc | 1.47% | 45,131 | 7.63K | Sep 29, 2024 |
| UBS Group AG | 0.06% | 1,889 | 319 | Sep 29, 2024 |